CROMWELL, Conn. & KIBBUTZ BEIT HAEMEK, Israel--(BUSINESS WIRE)--Biological Industries (“BI”) announced today a co-branding agreement with Corning Incorporated’s subsidiary, Mediatech, Inc., which will enable cell therapy, research, and manufacturing organizations around the world to purchase the innovative, xeno-free NutriStem® human pluripotent stem cell (“hPSC”) medium in conjunction with Corning’s existing portfolio of stem cell-focused technologies. Before the end of this year, Corning and BI will launch a jointly-branded NutriStem hPSC XF Medium, which will continue to be manufactured by BI, but marketed, distributed and supported worldwide by Corning’s global commercial team.
Key points:
- Under general terms, Corning will commercialize a joint-labeled NutriStem hPSC XF Medium.
- NutriStem hPSC XF Medium will continue to be manufactured by Biological Industries.
- BI and Biological Industries USA (BI USA), the US commercial arm of BI, will continue to directly offer NutriStem hPSC XF Medium and support researchers working with the medium.
“This co-branding agreement is an important milestone for us as we move more broadly and globally in commercializing our defined, xeno-free, and serum-free solutions for stem cell research,” said Alon Ariel, CEO, Biological Industries. “We chose to work with Corning, as an established global leader, to support our common goal of bringing together key technologies to benefit stem cell research and facilitate future clinical therapies.”
NutriStem hPSC XF Medium was developed and launched in 2009, and has been increasingly adopted by leading academic and commercial labs worldwide for use in the culture of pluripotent stem cells.
“This agreement builds on our proven expertise in developing media for hiPSC and hESC generation, expansion, and maintenance,” said Tanya Potcova, CEO of BI USA. “We look forward to a productive working relationship with Corning and the growing adoption of NutriStem hPSC XF Medium .”
To learn more about NutriStem hPSC XF Medium and BI’s other products, please visit www.bioind.com or call (860) 316-2702.
About Biological Industries
Biological Industries (www.bioind.com) is one of the world’s leading and trusted suppliers to the life sciences industry, with over 30 years’ experience in cell culture media development and manufacturing. BI’s products range from classical cell culture media to supplements and reagents for stem cell research and potential cell therapy applications to serum-free media and many other products for animal cell culture and molecular biology. BI is committed to a Culture of Excellence through advanced manufacturing and quality-control systems, regulatory expertise, in-depth market knowledge, and extensive technical customer-support, training, and R&D capabilities.
Biological Industries USA (BI USA) is the US commercialization arm of BI, with facilities in Cromwell, Connecticut.
To receive ongoing BI communications, please join our email list or connect with the company on LinkedIn, Twitter, and Facebook.
About Corning Incorporated
Corning (www.corning.com) is one of the world’s leading innovators in materials science. For more than 160 years, Corning has applied its unparalleled expertise in specialty glass, ceramics, and optical physics to develop products that have created new industries and transformed people’s lives. Corning succeeds through sustained investment in R&D, a unique combination of material and process innovation, and close collaboration with customers to solve tough technology challenges. Corning’s businesses and markets are constantly evolving. Today, Corning’s products enable diverse industries such as consumer electronics, telecommunications, transportation, and life sciences. They include damage-resistant cover glass for smartphones and tablets; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for high-speed communications networks; trusted products that accelerate drug discovery and manufacturing; and emissions-control products for cars, trucks, and off-road vehicles.